31.10.2012 • NewsBASFchemical industryAustralia

BASF Opens Global R&D Center for Mining in Australia

The chemical company BASF today opened its global mining research and development center at the Australian Minerals Research Centre (AMRC) in Perth, WA.

At the new facility, BASF scientists will study specific innovation needs for mineral processing and metal production, to help reduce energy and reuse water at mines in Australia and around the world.

The AMRC site is part of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency and one of the largest and most diverse research agencies in the world.

With a team of six advanced material researchers at the BASF center by the end of 2012 and about 20 researchers over the next five years, focus topics will include advanced rheology modifiers for the improvement of the thickening process for valuables and tailings, as well as modification of the crystallization process in alumina production.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.